SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Clarivate Plc (CLVT-PA) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 27/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CLVT-PA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.30
Book Value / Share$0.00
Revenue / Share$3.65
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$-0.86 |
$917.63M |
$-263.93M |
-28.8% |
| 2018 |
$-0.79 |
$968.47M |
$-242.16M |
-25% |
| 2019 |
$-0.39 |
$1.25B |
$-106.31M |
-8.5% |
| 2020 |
$-0.63 |
$1.88B |
$-270.45M |
-14.4% |
| 2021 |
$-0.61 |
$1.88B |
$-270.5M |
-14.4% |
| 2022 |
$-6.24 |
$2.66B |
$-3.96B |
-148.9% |
| 2023 |
$-1.47 |
$2.63B |
$-911.2M |
-34.7% |
| 2024 |
$-0.96 |
$2.56B |
$-636.7M |
-24.9% |
| 2025 |
$-0.30 |
$2.46B |
$-201.1M |
-8.2% |
